Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer

被引：0
|
作者：
Yuichi Ozawa
Daisuke Akahori
Keigo Koda
Takefumi Abe
Hirotsugu Hasegawa
Takashi Matsui
Masayuki Tanahashi
Hiroshi Niwa
Kazunari Yamada
Koshi Yokomura
Takafumi Suda
机构：
[1] Seirei Mikatahara General Hospital,Department of Respiratory Medicine, Respiratory Disease Center
[2] Seirei Mikatahara General Hospital,Division of Thoracic Surgery, Respiratory Disease Center
[3] Seirei Mikatahara General Hospital,Department of Radiation Oncology
[4] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
Lung cancer; Interstitial lung disease; Docetaxel; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1031 / 1038
页数：7
相关论文
共 50 条
  • [1] Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer
    Ozawa, Yuichi
    Akahori, Daisuke
    Koda, Keigo
    Abe, Takefumi
    Hasegawa, Hirotsugu
    Matsui, Takashi
    Tanahashi, Masayuki
    Niwa, Hiroshi
    Yamada, Kazunari
    Yokomura, Koshi
    Suda, Takafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 1031 - 1038
  • [2] The Risk Of Chemotherapy-Related Exacerbation Of Interstitial Lung Disease With Lung Cancer
    Kenmotsu, H.
    Naito, T.
    Akamatsu, H.
    Ono, A.
    Shukuya, T.
    Nakamura, Y.
    Tsuya, A.
    Kaira, K.
    Murakami, H.
    Takahashi, T.
    Endo, M.
    Yamamoto, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [3] The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kimura, Madoka
    Ono, Akira
    Shukuya, Takehito
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1242 - 1246
  • [4] THE RISK AND BENEFIT OF CHEMOTHERAPY IN PATIENTS WITH STAGE IV NON-SMALL LUNG CANCER PRE-EXISTING INTERSTITIAL LUNG DISEASE
    Takamura, K.
    Asahina, H.
    Oizumi, S.
    Fujita, Y.
    Kojima, T.
    Harada, T.
    Kawai, Y.
    Sasaki, T.
    Yamamoto, M.
    Dosaka-Akita, H.
    Isobe, H.
    Nishimura, M.
    RESPIROLOGY, 2012, 17 : 84 - 84
  • [5] The Incidence of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Ono, Akira
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S414 - S415
  • [6] Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?
    Zhu, Lin
    Gao, Rong
    Li, Han
    Zheng, Yahui
    Yang, Junling
    IMMUNOTHERAPY, 2024, 16 (07) : 465 - 480
  • [7] Clinical impact of pre-existing acute exacerbation in patients with interstitial lung disease who underwent lung transplantation
    Kim, Hyeon Hwa
    Kim, Ho Cheol
    Shim, Tae Sun
    Ahn, Jee Hwan
    Huh, Jin Won
    Hong, Sang-Bum
    Lee, Geun Dong
    Kim, Dong Kwan
    Park, Seung-Il
    Choi, Sehoon
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [8] Clinical impact of pre-existing acute exacerbation in patients with interstitial lung disease who underwent lung transplantation
    Hyeon Hwa Kim
    Ho Cheol Kim
    Tae Sun Shim
    Jee Hwan Ahn
    Jin Won Huh
    Sang-Bum Hong
    Geun Dong Lee
    Dong Kwan Kim
    Seung-Il Park
    Sehoon Choi
    Respiratory Research, 24
  • [9] Investigation of Lung Cancer Patients Receiving Immunotherapy with Pre-Existing Lung Disease
    Mcgovern, K.
    Seetharamu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S583
  • [10] Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease
    Yasunori Enomoto
    Naoki Inui
    Shiro Imokawa
    Masato Karayama
    Hirotsugu Hasegawa
    Yuichi Ozawa
    Takashi Matsui
    Koshi Yokomura
    Takafumi Suda
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 499 - 505
12345